Sort
39,280 grants matching “leukemia”
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
$318,513Feng-Chun Yang · University Of Miami School Of Medicine · R01 · FY2015 · CA
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
$318,513Feng-Chun Yang · University Of Miami School Of Medicine · R01 · FY2017 · CA
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
$318,513Andrew S Kraft · University Of Arizona · R01 · FY2016 · CA
Novel Compounds to Inactivate Oncogenic Fusion Proteins
$318,513Jeffrey A Toretsky · Georgetown University · R01 · FY2010 · CA
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$318,513Archibald S Perkins · University Of Rochester · R01 · FY2017 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$318,513Laura Maria Calvi · University Of Rochester · R01 · FY2013 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$318,513Laura Maria Calvi · University Of Rochester · R01 · FY2016 · CA
GENE EXPRESSION BY HUMAN GRANULOCYTIC EHRLICHIOSIS AG
$318,480Ohio State University · R01 · FY2000 · AI
Development of an HTS assay for ySas2/hMOF histone acetyltransferase inhibitors
$318,472Ronen Marmorstein · Wistar Institute · R01 · FY2012 · GM
Development of an HTS assay for ySas2/hMOF histone acetyltransferase inhibitors
$318,472Ronen Marmorstein · Wistar Institute · R01 · FY2011 · GM
Cell Processing and Storage
$318,460Shelly Heimfeld · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Epigenetic Regulation of Transcription by Mixed Lineage Leukemia Protein MLL1
$318,455Yali Dou · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Clonal hematopoiesis, mild cognitive impairment and kidney function decline
$318,452Michel Benjamin Chonchol · University Of Colorado Denver · R01 · FY2025 · AG
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
$318,441Jianjun Chen · University Of Cincinnati · R01 · FY2015 · CA
Cooperating genes in inv(16) acute myeloid leukemia
$318,398Univ Of Massachusetts Med Sch Worcester · R01 · FY2005 · CA
Cooperating genes in inv(16) acute myeloid leukemia
$318,398Univ Of Massachusetts Med Sch Worcester · R01 · FY2004 · CA
Cooperating genes in inv(16) acute myeloid leukemia
$318,398Univ Of Massachusetts Med Sch Worcester · R01 · FY2003 · CA
Oncogene-Induced Evasion from Apoptosis
$318,352Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2007 · CA
Expression and Function of Tob in T Lymphocytes
$318,352Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA
Oncogene-Induced Evasion from Apoptosis
$318,352Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Expression and Function of Tob in T Lymphocytes
$318,352Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Oncogene-Induced Evasion from Apoptosis
$318,352Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA
Targeting Acid Ceramidase in AML
$318,309Thomas P Loughran · University Of Virginia · P01 · FY2024 · CA
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
$318,308Baylor College Of Medicine · R01 · FY2005 · CA
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
$318,308Baylor College Of Medicine · R01 · FY2004 · CA